Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07356960
What this trial is testing

Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world

Who this might be right for
Acute Lymphobkastic LeukemiaPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 103
Not applicableActive Not RecruitingNCT04108624
What this trial is testing

Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
University of Chicago 68
Not applicableStudy completedNCT05393024
What this trial is testing

Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 78
Not applicableLooking for participantsNCT05858424
What this trial is testing

Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer

Who this might be right for
Solid TumorLymphoma
Centre Leon Berard 214
Early research (Phase 1)Study completedNCT02426723
What this trial is testing

Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients

Who this might be right for
Multiple Myeloma
JW Pharmaceutical 25
Large-scale testing (Phase 3)Looking for participantsNCT03593759
What this trial is testing

Cardiac Sarcoidosis Randomized Trial

Who this might be right for
Cardiac SarcoidosisSarcoidosis
Ottawa Heart Institute Research Corporation 160
Testing effectiveness (Phase 2)Study completedNCT01057225
What this trial is testing

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma

Who this might be right for
Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Mayo Clinic 64
Not applicableStudy completedNCT02187276
What this trial is testing

The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia

Who this might be right for
Alzheimer Disease, Late Onset
Federal University of Minas Gerais 129
Post-approval studies (Phase 4)UnknownNCT05786989
What this trial is testing

Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Chongqing University Cancer Hospital 32
Early research (Phase 1)Study completedNCT00345189
What this trial is testing

Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors

Who this might be right for
TumorsLymphoma
Biogen 70
Large-scale testing (Phase 3)Study completedNCT03170050
What this trial is testing

Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds

Who this might be right for
Wrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial Folds
Yooyoung Pharmaceutical Co., Ltd. 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155191
What this trial is testing

Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Lymphoblastic Leukemia, Acute Adult
Takara Bio Inc. 21
Not applicableEnded earlyNCT02394210
What this trial is testing

Post-authorisation Study of Biological Relapse in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 415
Testing effectiveness (Phase 2)Ended earlyNCT00003113
What this trial is testing

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center 6
Large-scale testing (Phase 3)Active Not RecruitingNCT05556720
What this trial is testing

Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

Who this might be right for
HIVOrgan TransplantationLymphoma, Non-Hodgkin+3 more
Monash University 960
Testing effectiveness (Phase 2)Study completedNCT03096782
What this trial is testing

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia+19 more
M.D. Anderson Cancer Center 6
Not applicableNo Longer AvailableNCT01200017
What this trial is testing

Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+9 more
Christopher Dvorak
Large-scale testing (Phase 3)UnknownNCT02757040
What this trial is testing

Combination of Ibrutinib and As2O3 in the Treatment of CLL

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00965289
What this trial is testing

High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma

Who this might be right for
B-Cell Lymphoma
Nantes University Hospital 42
Testing effectiveness (Phase 2)Ended earlyNCT01343368
What this trial is testing

Preservation of Ovarian Function After Hematopoietic Cell Transplant

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaHodgkin Disease+2 more
Masonic Cancer Center, University of Minnesota 19
Next Page